The use of DC vaccines is a therapeutic method in which antigen-loaded DCs are stimulated by anti-inflammatory cytokines and delivered to promote the anti-tumour immune responses of tumour antigen-specific CD8+ T cells [89]. Here, CD8A is linked to neoplasm.